BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 4597632)

  • 1. The fibrinolytic enzyme system in haematological malignancy.
    Dawson AA; Ogston D; Douglas AS
    Bibl Anat; 1973; 12():272-8. PubMed ID: 4597632
    [No Abstract]   [Full Text] [Related]  

  • 2. The fibrinolytic enzyme system in leukaemia, myelomatosis and myeloproliferative diseases.
    Ogston D; Dawson AA; Adam HM
    Acta Haematol; 1972; 48(6):322-30. PubMed ID: 4633099
    [No Abstract]   [Full Text] [Related]  

  • 3. [Haptoglobin level in multiple myeloma, lymphatic leukemia and other proliferative disorders of the lymphoreticular system].
    Cieśluk S; Snigurowicz J
    Pol Tyg Lek; 1970 Jul; 25(28):1048-50. PubMed ID: 5468584
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of "virus-like" particles in the plasmas of 255 patients with leukemia and related diseases.
    Newell GR; Harris WW; Bowman KO; Boone CW; Anderson NG
    N Engl J Med; 1968 May; 278(22):1185-91. PubMed ID: 4172474
    [No Abstract]   [Full Text] [Related]  

  • 5. [Determination of beta 1 C-A (complement factor 3) in malignant lymphoma, myeloma, and Waldenström's disease].
    Meier EC; Grob PJ
    Dtsch Med Wochenschr; 1972 Jun; 97(25):967-71. PubMed ID: 4624059
    [No Abstract]   [Full Text] [Related]  

  • 6. [Metabolism of blood leukocytes in patients with malignant hemopathies and hematosarcomas during the course of chemotherapy].
    Lille I; Gabay P; Clavel B; Saracino RT; Bourdin JS
    Nouv Rev Fr Hematol; 1969; 9(5):715-21. PubMed ID: 4244273
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood plasminogen (profibrinolysin) levels in patients with leukemia and lymphoma.
    Girolami A; Mootse G; Cliffton EE
    Am J Med Sci; 1967 Sep; 254(3):334-41. PubMed ID: 4861481
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lymphocyte culture in the presence of phytohemagglutinins in Hodgkin's disease].
    Ferrari S; Foggi CM; Serafini NA
    Ann Ist Carlo Forlanini; 1968; 28(3):292-309. PubMed ID: 4903142
    [No Abstract]   [Full Text] [Related]  

  • 9. The fibrinolytic enzyme system in malignant lymphomas.
    Ogston D; Dawson A
    Acta Haematol; 1973; 49(2):89-95. PubMed ID: 4196481
    [No Abstract]   [Full Text] [Related]  

  • 10. [Total serum copper in histiocyte sarcomatosis with a systemic tendency].
    Papa G; de Laurenzi A; Amadori S
    Haematologica; 1972; 57(3):179-83. PubMed ID: 4625059
    [No Abstract]   [Full Text] [Related]  

  • 11. [The primary proliferative processes of the hemopoietic system].
    Introzzi P
    Minerva Med; 1969 Sep; 60(74):3399-450. PubMed ID: 4981171
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibrinolysis in myelomatosis.
    Preston FE; Lee D
    Acta Haematol; 1972; 47(2):65-70. PubMed ID: 4623361
    [No Abstract]   [Full Text] [Related]  

  • 13. [The alkaline phosphatase of the leukocytes (LAP) during hemoblastosis].
    GATTI A; GIUSTINA G; LIBRO D; MAGGI N
    Prog Med (Napoli); 1961 Jun; 17():365-71. PubMed ID: 13703931
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
    Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
    Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen deposition and macrophage-associated fibrin formation in malignant and nonmalignant lymphoid tissue.
    Costantini V; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Rousseau SM; Stump DC
    J Lab Clin Med; 1992 Feb; 119(2):124-31. PubMed ID: 1740624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study by means of P.A.S. of peripheral blood lymphocytes in Waldenstrom's disease and in African trypanosomiasis].
    Moretti G; Veyret V; Broustet A
    Nouv Rev Fr Hematol; 1969; 9(5):741-6. PubMed ID: 4189942
    [No Abstract]   [Full Text] [Related]  

  • 17. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of paper electrophoretic and immunoelectrophoretic studies of the serum proteins of patients with lymphomas and leukemias.
    Leoncini D; Forni A; Korngold L; Miller DG
    Oncology; 1968; 22(2):81-117. PubMed ID: 4880062
    [No Abstract]   [Full Text] [Related]  

  • 19. [HL-A antigens and malignant hematological diseases].
    Jeannet M; Alberto P; Wyss M
    Schweiz Med Wochenschr; 1971 Dec; 101(49):1798-800. PubMed ID: 5291103
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum lactic dehydrogenase activity in myeloproliferative and lymphoproliferative disorders.
    Woodliff HJ; Lynch W
    Med J Aust; 1967 Mar; 1(9):431-2. PubMed ID: 5336861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.